Suppression of IL-23-mediated psoriasis-like inflammation by regulatory B cells
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Suppression of IL-23-mediated psoriasis-like inflammation by regulatory B cells
Authors
Keywords
-
Journal
Scientific Reports
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-22
DOI
10.1038/s41598-021-81588-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Local reinfusion of B10 cells is effective in the treatment of pustular psoriasis
- (2020) Jiajing Lu et al. Dermatologic Therapy
- Attenuation of murine sclerodermatous models by the selective S1P1 receptor modulator cenerimod
- (2019) Miyu Kano et al. Scientific Reports
- Apremilast increases IL-10-producing regulatory B cells and decreases proinflammatory T cells and innate cells in psoriatic arthritis and psoriasis
- (2019) Athanasios Mavropoulos et al. RHEUMATOLOGY
- BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance
- (2018) Takashi Matsushita et al. Science Advances
- Regulatory and effector B cells: Friends or foes?
- (2018) Takashi Matsushita JOURNAL OF DERMATOLOGICAL SCIENCE
- A novel splenic B1 regulatory cell subset suppresses allergic disease through phosphatidylinositol 3-kinase–Akt pathway activation
- (2016) Takashi Matsushita et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IL-10-producing regulatory B cells are decreased in patients with psoriasis
- (2016) Mitsuha Hayashi et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells
- (2016) Hani Alrefai et al. Nature Communications
- The expanding family of regulatory B cells
- (2015) Claudia Mauri et al. INTERNATIONAL IMMUNOLOGY
- Decreased levels of regulatory B cells in patients with systemic sclerosis: association with autoantibody production and disease activity
- (2015) Takashi Matsushita et al. RHEUMATOLOGY
- B Cells Promote Tumor Immunity against B16F10 Melanoma
- (2014) Tadahiro Kobayashi et al. AMERICAN JOURNAL OF PATHOLOGY
- Regulatory B cells in autoimmune diseases
- (2013) Min Yang et al. Cellular & Molecular Immunology
- Regulatory B cells suppress imiquimod-induced, psoriasis-like skin inflammation
- (2013) Koichi Yanaba et al. JOURNAL OF LEUKOCYTE BIOLOGY
- CD19+CD24hiCD38hi B Cells Maintain Regulatory T Cells While Limiting TH1 and TH17 Differentiation
- (2013) F. Flores-Borja et al. Science Translational Medicine
- Novel regulatory functions for Toll-like receptor-activated B cells during intracellular bacterial infection
- (2011) Simon Fillatreau IMMUNOLOGICAL REVIEWS
- B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer
- (2010) David J. DiLillo et al. Annals of the New York Academy of Sciences
- Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells
- (2010) Y. Iwata et al. BLOOD
- Regulation of immunity and autoimmunity by B cells
- (2010) Claudia Mauri CURRENT OPINION IN IMMUNOLOGY
- Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model
- (2010) Sylvie Amu et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IL-23-Mediated Psoriasis-Like Epidermal Hyperplasia Is Dependent on IL-17A
- (2010) H. L. Rizzo et al. JOURNAL OF IMMUNOLOGY
- Regulatory B Cells (B10 Cells) and Regulatory T Cells Have Independent Roles in Controlling Experimental Autoimmune Encephalomyelitis Initiation and Late-Phase Immunopathogenesis
- (2010) T. Matsushita et al. JOURNAL OF IMMUNOLOGY
- Regulatory B Cells (B10 Cells) Have a Suppressive Role in Murine Lupus: CD19 and B10 Cell Deficiency Exacerbates Systemic Autoimmunity
- (2010) R. Watanabe et al. JOURNAL OF IMMUNOLOGY
- CCR6 is required for IL-23–induced psoriasis-like inflammation in mice
- (2009) Michael N. Hedrick et al. JOURNAL OF CLINICAL INVESTIGATION
- Selective Targeting of B Cells with Agonistic Anti-CD40 Is an Efficacious Strategy for the Generation of Induced Regulatory T2-Like B Cells and for the Suppression of Lupus in MRL/lpr Mice
- (2009) P. A. Blair et al. JOURNAL OF IMMUNOLOGY
- The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis
- (2009) Antonella Di Cesare et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Psoriasis
- (2009) Frank O. Nestle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Onset of psoriasis with psoriatic arthropathy during rituximab treatment of non-Hodgkin lymphoma
- (2008) F Mielke et al. ANNALS OF THE RHEUMATIC DISEASES
- Successful treatment of psoriatic arthritis with rituximab
- (2008) J D Cohen ANNALS OF THE RHEUMATIC DISEASES
- B lymphocytes: how they develop and function
- (2008) T. W. LeBien et al. BLOOD
- A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses
- (2008) Koichi Yanaba et al. IMMUNITY
- Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
- (2008) Takashi Matsushita et al. JOURNAL OF CLINICAL INVESTIGATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started